Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023
American Academy of Neurology Telehealth Position Statement
Neurol 97:334-339, Hatcher-Martin, J.M.,et al, 2021
Preparing a Neurology Department for SARS-CoV-2 (COVID-19)
Neurol 94:886-891, Waldman, G.,et al, 2020
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
Clinicopathologic Conference, Cerebrovascular Accident Probably Related to SARS-CoV2 Infection
NEJM 383:764-773, Case 26-2020, 2020
End of Life
Neurol 93:729-734, Masdeu, J.C.,et al, 2019
A Headache of a Diagnosis
NEJM 379:475-479, Stern,R.M.,et al, 2018
Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies
JAMA Neurol 72:874-881,861, Arino, H.,et al, 2015
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014
Neurologic Complications of Influenza A (H1N1)pdm09
Neurol 79:1474-1481, Khandaker,G.,et al, 2012
Do You Measure Up: Further Steps Toward Standardization and Measuring Quality in Neurologic Care
Neurol 76:16-17, Britton,J.W., 2011
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
Practice Parameter: Assessing Patients in a Neurology Practice for Risk of Falls (An Evidence-Based Review)
Neurol 70:473-479, Thurman,D.J.,et al, 2008
Neurologic Aspects of Infections in International Travelers
The Neurologist 11:30-44, Han,M.H. &Zunt,J.R., 2005
Position Statement Regarding the Use of Embryonic and Adult Human Stem Cells in Biomedical Research
Neurol 64:1679-1680,1675, American academy of Neurology and American Neurological Association, 2005
Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes
JNNP 75:1135-1140,1090, Graus,F.,et al, 2004
Quantitative Sensory Testing, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 60:898-904, Shy,M.E.,et al, 2003
West Nile Virus: A Primer for the Clinician
Ann Int Med 137:173-179, Petersen,L.R. &Marfin,A.A., 2002
Illness After International Travel
NEJM 347:505-516, Ryan,E.T.,et al, 2002
Epidemic West Nile Encephalitis, New York, 1999: Results of a Household-based Seroepidemiological Survey
Lancet 358:261-264,254, Mostashari,F.,et al, 2001
Neurological Manifestations of Dengue Infection
Lancet 355:1053-1059, Solomon,T.,et al, 2000
Assisted Suicide
Euthanasia, and the Neurologist, The Ethics and Humanities Subcom of AAN, Neurol 50:596-59898., , 1998
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Assessment of Plasmapheresis
Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Assessment:Electronystagmography, Report of the Therapeutics and Technology Assessment Subcommittee
Neurol 46:1763-1766, Ferguson,J.H.,et al, 1996
Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996
Guidelines on the Detection of Paraneoplastic Anti-Neuronal-Specific Antibodies
Neurol 45:1937-1941, Moll,J.W.B.,et al, 1995
Can Neurologists Survive or Thrive with Health Care Reform
Ann Neurol 33:441-444, Ringel,S.P., 1993
The Spectrum of Neurological Disease in Patients with Systemic Cancer
Ann Neurol 31:268-273, Clouston,P.D.,et al, 1992
Clinical Audit and Neurology
Hopkins. A. , JNNP 55 (Suppl) :19-25., , 1992
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992